In This Article:
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Picking the right S&P 500 stocks requires more than just buying big names, and that’s where StockStory comes in. That said, here are three S&P 500 stocks to steer clear of and a few alternatives to consider.
Honeywell (HON)
Market Cap: $143.2 billion
Originally founded in 1906 as a thermostat company, Honeywell (NASDAQ:HON) is a multinational conglomerate known for its aerospace systems, building technologies, performance materials, and safety and productivity solutions.
Why Do We Think Twice About HON?
-
Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
-
Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 3.3%
-
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.2 percentage points
Honeywell is trading at $225.13 per share, or 21.2x forward P/E. If you’re considering HON for your portfolio, see our FREE research report to learn more.
Lockheed Martin (LMT)
Market Cap: $109.7 billion
Headquartered in Maryland, Famous for the F-35 aircraft, Lockheed Martin (NYSE:LMT) specializes in defense, space, homeland security, and information technology products.
Why Do We Avoid LMT?
-
Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 3.3% over the last five years was below our standards for the industrials sector
-
Incremental sales over the last five years were less profitable as its earnings per share were flat while its revenue grew
-
Waning returns on capital imply its previous profit engines are losing steam
Lockheed Martin’s stock price of $474 implies a valuation ratio of 16.8x forward P/E. To fully understand why you should be careful with LMT, check out our full research report (it’s free).
STERIS (STE)
Market Cap: $24.72 billion
With a mission critical role in preventing healthcare-associated infections, STERIS (NYSE:STE) provides infection prevention products, sterilization services, and medical equipment that help healthcare facilities and life science companies maintain sterile environments.
Why Are We Cautious About STE?
-
Adjusted operating margin failed to increase over the last two years, indicating the company couldn’t optimize its expenses
-
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.1 percentage points
-
Below-average returns on capital indicate management struggled to find compelling investment opportunities